Insider Transactions in Q3 2024 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 04
2024
|
Michael Mano SVP, General Counsel&Secretary |
SELL
Open market or private sale
|
Direct |
3,971
-1.43%
|
$0
$0.72 P/Share
|
|
Sep 04
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,667
-0.32%
|
$0
$0.72 P/Share
|
|
Sep 04
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
7,050
-1.77%
|
$0
$0.72 P/Share
|
|
Sep 04
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,356
-1.31%
|
$0
$0.72 P/Share
|
|
Aug 06
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,608
-0.31%
|
$0
$0.93 P/Share
|
|
Jul 30
2024
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,883
-0.87%
|
$2,883
$1.06 P/Share
|
|
Jul 05
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,616
-0.31%
|
$0
$0.85 P/Share
|